RecruitingNot ApplicableNCT06524180

Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension

Can TElemedicine System Replace Doctor Consultations to Achieve Non-inferior Blood Pressure in Patients With Controlled Hypertension (TEACH)? a Randomised Controlled Trial and Cost-minimization Analysis


Sponsor

Chinese University of Hong Kong

Enrollment

364 participants

Start Date

Oct 1, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to evaluate whether patients assigned to the telemedicine (HealthCap) group demonstrate non-inferior blood pressure (BP) control compared to patients in the usual care group at 12 months. The main question it aims to answer is: * Do participants in telemedicine group have non-inferior daytime ambulatory blood pressure readings at 12-month, compared to usual care group? * Do participants in telemedicine group have better HT treatment, higher self-efficacy, reduced number of visits to primary care clinics and similar health care utilisation other than GOPCs, compared to usual care group? Participant in telemedicine group will: * Receive reminders to measure 7-day home blood pressure before their index consultation. * Get their drug refilled automatically as well as have consultations deferred 16-18 weeks later, if their blood pressure is under optimal control. * Have consultations as scheduled, if their BP is suboptimal or any of the safety questions screen positive. Participants in control group will: * Have consultation with physicians every 16-18 weeks.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a telemedicine (remote care) app called HealthCap can manage blood pressure in patients with controlled hypertension just as well as regular in-person doctor visits. If successful, this could reduce the need for frequent clinic appointments for people whose blood pressure is already well-managed. **You may be eligible if...** - You have been diagnosed with essential hypertension (high blood pressure not caused by another condition) - You are currently on blood pressure medication - Your blood pressure is well-controlled based on home or ambulatory blood pressure readings (below 135/85 mmHg, or 130/85 mmHg if you have diabetes, kidney disease, or heart disease) - You can read basic Chinese (the language used in the HealthCap app) - You have used any mobile app in the past year - You are between 18 and 80 years old **You may NOT be eligible if...** - You are unable to give informed consent - You are unwilling to do home blood pressure monitoring - You have atrial fibrillation, work night shifts, or have bleeding tendencies (making blood pressure monitoring difficult) - You have a serious mental illness affecting your ability to use the app - You have other conditions requiring regular medication changes (e.g., poorly controlled diabetes, active cancer) - Your expected survival is less than 1 year Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETelemedicine

a mobile app and telemedicine platform to confirm good blood pressure control and may save doctor face-to-face consultation

OTHERUsual care

Participants will be followed up as usual by face-to-face consultation with the doctors


Locations(1)

HKW and NTEC GOPC

Hong Kong, Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06524180


Related Trials